Literature DB >> 12547224

Pathways of iron absorption.

Marcel E Conrad1, Jay N Umbreit.   

Abstract

Iron is vital for all living organisms but excess iron can be lethal because it facilitates free radical formation. Thus iron absorption is carefully regulated to maintain an equilibrium between absorption and body loss of iron. In countries where meat is a significant part of the diet, most body iron is derived from dietary heme because heme binds few of the dietary chelators that bind inorganic iron. Uptake of heme into enterocytes occurs as a metalloporphyrin in an endosomal process. Intracellular iron is released from heme by heme oxygenase to enter plasma as inorganic iron. Ferric iron is absorbed via a beta(3) integrin and mobilferrin pathway (IMP) which is unshared with other nutritional metals. Ferrous iron uptake is facilitated by a DMT-1 pathway which is shared with manganese. In the iron deficient gut, large quantities of both mobilferrin and DMT-1 are found in goblet cells and intraluminal mucins suggesting that they are secreted with mucin into the intestinal lumen to bind iron to facilitate uptake by the cells. In the cytoplasm, IMP and DMT associate in a large protein complex called paraferritin which serves as a ferrireductase. Paraferritin solublizes iron binding proteins and reduces iron to make iron available for production of iron containing proteins such as heme. Iron uptake by intestinal absorptive cells is regulated by the iron concentration within the cell. Except in hemochromatosis it remains in equilibrium with total body stores via transferrin receptors on the basolateral membrane of absorptive cells. Increased intracellular iron either up-regulates or satiates iron binding proteins on regulatory proteins to alter their location in the intestinal mucosa.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12547224     DOI: 10.1006/bcmd.2002.0564

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  36 in total

Review 1.  Synthetic and natural iron chelators: therapeutic potential and clinical use.

Authors:  Heather C Hatcher; Ravi N Singh; Frank M Torti; Suzy V Torti
Journal:  Future Med Chem       Date:  2009-12       Impact factor: 3.808

Review 2.  The gut in iron homeostasis: role of HIF-2 under normal and pathological conditions.

Authors:  Maria Mastrogiannaki; Pavle Matak; Carole Peyssonnaux
Journal:  Blood       Date:  2013-05-15       Impact factor: 22.113

3.  Effects of the nephrilin peptide on post-burn glycemic control, renal function, fat and lean body mass, and wound healing.

Authors:  Desmond D Mascarenhas; Amina El Ayadi; Michael Wetzel; Anesh Prasai; Randy Mifflin; Jayson Jay; David N Herndon; Celeste C Finnerty
Journal:  Int J Burns Trauma       Date:  2016-11-30

4.  Evidence for a sequential transfer of iron amongst ferritin, transferrin and transferrin receptor during duodenal absorption of iron in rat and human.

Authors:  Vasantha L Kolachala; B Sesikeran; K Madhavan Nair
Journal:  World J Gastroenterol       Date:  2007-02-21       Impact factor: 5.742

5.  In vitro assessment of bio-augmented minerals from peanut oil cakes fermented by Aspergillus oryzae through Caco-2 cells.

Authors:  Pardeep Kumar Sadh; Prince Chawla; Latika Bhandari; Ravinder Kaushik; Joginder Singh Duhan
Journal:  J Food Sci Technol       Date:  2017-09-09       Impact factor: 2.701

Review 6.  Control of intracellular heme levels: heme transporters and heme oxygenases.

Authors:  Anwar A Khan; John G Quigley
Journal:  Biochim Biophys Acta       Date:  2011-01-14

7.  Differences in the uptake of iron from Fe(II) ascorbate and Fe(III) citrate by IEC-6 cells and the involvement of ferroportin/IREG-1/MTP-1/SLC40A1.

Authors:  Carla Thomas; Phillip S Oates
Journal:  Pflugers Arch       Date:  2004-04-28       Impact factor: 3.657

Review 8.  Phytate: impact on environment and human nutrition. A challenge for molecular breeding.

Authors:  Lisbeth Bohn; Anne S Meyer; Søren K Rasmussen
Journal:  J Zhejiang Univ Sci B       Date:  2008-03       Impact factor: 3.066

9.  Roles of hormone replacement therapy and iron in proliferation of breast epithelial cells with different estrogen and progesterone receptor status.

Authors:  Jisen Dai; Jinlong Jian; Maarten Bosland; Krystyna Frenkel; Güenther Bernhardt; Xi Huang
Journal:  Breast       Date:  2007-10-24       Impact factor: 4.380

10.  Relative bioavailability of iron and folic acid from a new powdered supplement compared to a traditional tablet in pregnant women.

Authors:  Brenda Hartman-Craven; Anna Christofides; Deborah L O'Connor; Stanley Zlotkin
Journal:  BMC Pregnancy Childbirth       Date:  2009-07-27       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.